Trial aims to improve therapy access for insomnia The pilot is designed to better support GPs with management, referral pathways and non-drug interventions for patients with insomnia.
Codeine use down by 37% since up-scheduling Use of the drug has dropped substantially across all jurisdictions, a new wastewater-based epidemiology report suggests.
Study weighs up impact of different drug dosages for men and women New research that has found women are not just ‘smaller versions of men’ could help to reduce adverse reactions to medication.
Widespread concerns flagged about NPS MedicineWise demise Many worry about the impact on the safe use of medicine, while the transfer of skills is another key issue with employees already leaving.
Clarity on Close the Gap Co-payment initiative Some Aboriginal and Torres Strait Islander patients are being incorrectly told they are no longer able to register for the PBS-subsidised program.
Health Minister confirms NPS MedicineWise cuts Despite appeals to overturn a decision under the previous Government to remove funding from NPS MedicineWise, the original decision will stand.
Could anticipatory deprescribing allow better COVID treatment? Despite being more effective according to some studies, Paxlovid prescriptions lag Lagevrio, with drug–drug interactions likely to play a part.
New alcohol and other drugs resource for GPs A wide range of clinical guidance is now available in a ‘one-stop shop’ to help general practices care for patients.
Australia’s first fixed pill-testing site opens in ACT The Chair of RACGP Specific Interests Addiction Medicine has welcomed the ‘highly significant’ launch, which is part of a six-month trial.
‘We have deep concerns’: NPS MedicineWise fights funding cuts Leaders at the organisation, which had its funding removed in the most recent budget, are calling for the decision to be reviewed.